Global Access Strategy Lead (Belgium)

Make your mark for patients

We are looking for a Global Access Strategy Lead who is strategic influential and collaborative to join our HTA & Payers team based in Slough UK or Brussels Belgium.

About the Role

As the Evidence Synthesis Lead you will hold a senior global access leadership role with accountability for shaping and driving payer-focused access strategy across assigned assets and indications.

You will ensure that payer evidence pricingrelevant insights and value narratives are fully embedded in asset strategy governance decisionmaking negotiation readiness and lifecycle planning. Shaping the global access strategy you will translate complex payer HTA and evidence landscapes into clear strategic choices that enable confident decisions..

Acting as a strategic integrator across Market Access Pricing RealWorld Evidence (RWE) Health Economics Clinical and Asset Strategy you will translate complex evidence landscapes into clear strategic options tradeoffs and recommendations..

Who Youll Work With

You will report to the Head of Payer Evidence Synthesis and work closely with Asset Sub Teams Integrated Strategic Evidence Generation (ISEG) teams global and regional Market Access colleagues Pricing RWE Health Economics Clinical Development and the HTA & Payers community. You will also engage with senior governance forums to represent the payer perspective and guide strategic decisions.

What Youll Do

• Act as the access strategy lead for the assigned asset embedding payer perspectives across the lifecycle.
• Translate payer insights evidence gaps and market dynamics into clear strategic options and recommendations.
• Align global regional and local teams around a shared decisionready access strategy.
• Lead the development of Global Value Dossiers HTA dossiers payer value narratives and related deliverables.
• Ensure payer evidence supports HTA outcomes negotiations and lifecycle access decisions.
• Drive early HTA engagement strategies and ensure readiness for EU Joint Clinical Assessment (JCA) requirements (where applicable).
• Integrate external payer HTA and policy intelligence into forwardlooking access strategies.
• Partner with the Strategic Pricing teams to translate payer evidence into pricingrelevant insights and negotiation readiness.
• Define and prioritise payerdriven RWE questions in partnership with RWE Strategy leads.
• Enable coach and upskill regional and local teams to drive highquality access execution (where appropriate).
  
  

Interested For this role were looking for:

• 10 years experience in the biopharmaceutical industry across Market Access HTA pricing or evidencegeneration roles.
• 36 years experience in global or regional Market Access HEOR HTA pricing or consulting positions.
• Proven ability to lead assetlevel access strategy in complex matrix organisations.
• Strong experience partnering with Pricing Strategy on launch and lifecycle decisions.
• Bachelors degree in a relevant discipline; advanced degree (MBA MSc PhD) preferred.
• Strong strategic thinking executive communication and stakeholderinfluencing skills.

Are you ready to go beyond to create value and make your mark for patients If this sounds like you then we would love to hear from you!

About us
UCB is a global biopharmaceutical company focusing on neurology and immunology. We are over 9.000 people in all four corners of the globe inspired by patients and driven by science.

Why work with us
At UCB we dont just complete tasks we create value. We arent afraid to push forward collaborate and innovate to make our mark for patients. We have a caring supportive culture where everyone feels included respected and has equal opportunities to do their best work. We go beyond to create value for our patients and always with a human focus whether thats on our patients our employees or our planet. Working for us you will discover a place where you can grow and have the freedom to carve your own career path to achieve your full potential.

At UCB weve embraced a hybrid-first approach to work bringing teams together in local hubs to foster collaborative curiosity. Unless expressly stated in the description or precluded by the nature of the position roles are hybrid with 40% of your time spent in the office.

UCB is an equal opportunity employer. All employment decisions will be made without regard to any characteristic protected by applicable laws.

Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on Please note should your enquiry not relate to adjustments; we will not be able to support you through this channel.